Wolverine Trading
CRMD icon

Wolverine Trading’s CorMedix CRMD Stock Holding History

Wolverine Trading’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,700
Closed -$334K – 5699
2025
Q2 		$334K Sell
26,700
-22,500
-46% -$248K ﹤0.01% 3368
2025
Q1 		$332K Buy
49,200
+27,600
+128% +$286K ﹤0.01% 3412
2024
Q4 		$175K Buy
21,600
+6,900
+47% +$68.9K ﹤0.01% 4597
2024
Q3 		$118K Buy
14,700
+1,800
+14% +$9.74K ﹤0.01% 4303
2024
Q2 		$55.9K Sell
12,900
-5,900
-31% -$30K ﹤0.01% 4205
2024
Q1 		$79.7K Buy
18,800
+4,700
+33% +$16.3K ﹤0.01% 4108
2023
Q4 		$53K Buy
+14,100
New +$48.5K ﹤0.01% 4244
2023
Q3 		– Sell
-11,300
Closed -$44.5K – 4581
2023
Q2 		$44.5K Sell
11,300
-3,100
-22% -$15.3K ﹤0.01% 3976
2023
Q1 		$60K Sell
14,400
-7,300
-34% -$29.9K ﹤0.01% 3798
2022
Q4 		$92K Sell
21,700
-10,800
-33% -$38.2K ﹤0.01% 3433
2022
Q3 		$92K Buy
32,500
+20,200
+164% +$84K ﹤0.01% 3951
2022
Q2 		$44K Buy
+12,300
New +$45.7K ﹤0.01% 4102
2022
Q1 		– Sell
-14,500
Closed -$68K – 5557
2021
Q4 		$68K Sell
14,500
-10,000
-41% -$49.6K ﹤0.01% 5229
2021
Q3 		$114K Buy
24,500
+8,900
+57% +$51.8K ﹤0.01% 5701
2021
Q2 		$112K Buy
+15,600
New +$124K ﹤0.01% 5346
2021
Q1 		– Sell
-12,700
Closed -$94K – 5930
2020
Q4 		$94K Buy
12,700
+2,700
+27% +$18.4K ﹤0.01% 4481
2020
Q3 		$59K Sell
10,000
-5,400
-35% -$27.1K ﹤0.01% 4252
2020
Q2 		$95K Buy
15,400
+3,900
+34% +$18.1K ﹤0.01% 4152
2020
Q1 		$41K Sell
11,500
-34,100
-75% -$193K ﹤0.01% 4314
2019
Q4 		$313K Buy
+45,600
New +$279K ﹤0.01% 3542
2019
Q3 		– Sell
-19,000
Closed -$170K – 4417
2019
Q2 		$170K Sell
19,000
-2,900
-13% -$22.8K ﹤0.01% 3800
2019
Q1 		$207K Buy
+21,900
New +$197K ﹤0.01% 3784

Other funds holding CRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolverine Trading's CRMD Position: Q2 2025 in Review

Wolverine Trading sold out of CorMedix (CRMD) in Q2 2025, closing a stake of 45,937 shares — an estimated $507K sold.

Wolverine Trading first reported a position in CRMD in Q4 2019 and held it in 18 quarters. The position peaked at $365K in Q3 2024. 172 funds tracked by Wall St. Rank hold CRMD as of Q2 2025.

  • Wolverine Trading reported no remaining CorMedix position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 45,937 CorMedix shares in Q2 2025, an estimated $507K.
  • Wolverine Trading first reported a position in CorMedix in Q4 2019 and held it in 18 quarters.
  • Wolverine Trading's CorMedix position peaked at $365K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held CorMedix as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.